Image de couverture de livre

ECT2 is a sensitive and specific marker of transformation in the human breast.

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Gasdermin activation during lineage specification in the human embryo.
par: Mamoor, Shahan
Publié: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

SSX2IP induction in basal subtype breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
par: Mamoor, Shahan
Publié: (2026)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
par: Mamoor, Shahan
Publié: (2026)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
par: Mamoor, Shahan
Publié: (2025)

Developmental stage-specific control of proliferation and senescence by EZH2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
par: Mamoor, Shahan
Publié: (2026)

Phosphatase targeting in Luminal B breast cancer: PGP.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
par: Mamoor, Shahan
Publié: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
par: Mamoor, Shahan
Publié: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
par: Mamoor, Shahan
Publié: (2025)